Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor
J Med Chem. 2019 Sep 12;62(17):8364.
doi: 10.1021/acs.jmedchem.9b01259.
Epub 2019 Aug 19.